Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial (Q58000796)
article
Language:
(P31) (Q13442814)
(P50) (Q37838345)
(Q47006499)
(P304) 111-118
(P433) 2
(P478) 12
(P577) Thursday, October 20, 2011
(P921) (Q937224)
(P1433) (Q15724248)
(P1476) "Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial" (language: en)
(P2093) Franco Maggiolo
Aza Rakhmanova
Patrick Yeni
Benjamin Young
Steve Almond
Ivy Song
Cindy Brothers
Sherene Min
Jan van Lunzen
(P2860) (Q34397376)
(Q43092892)
(Q28288290)
(Q42111140)
(Q33559015)
(Q39734035)
(Q38627271)
(Q27670616)
(Q47156478)
(Q28242324)
(Q93569641)
(Q45405108)
(Q46843159)
(Q38375842)
other details
description article

External Links